HPLC PURITY
99.0%
BATCH
NXG-2026-Q2-005
Semaglutide — 5mg
Semaglutide is a long-acting GLP-1 receptor agonist peptide with a C18 fatty diacid modification enabling albumin binding. This structural feature prolongs pharmacokinetic half-life in preclinical pharmacology research. The compound is provided for in vitro receptor binding studies and research applications only.
Select Size
Quantity
SKU: NXG-SEM-5MG
FOR IN-VITRO RESEARCH USE ONLY · NOT FOR HUMAN OR VETERINARY USE · PURCHASE REQUIRES RESEARCHER ATTESTATION
Research Mechanism
In research preparations, Semaglutide demonstrates high-affinity binding to GLP-1 receptors (GLP-1R) with activation of adenylyl cyclase and elevation of intracellular cAMP. Research applications include GLP-1R signaling studies, beta-cell biology models, and structure-activity relationship investigations.
This information is provided for research reference only. No claims are made regarding therapeutic efficacy or safety for human use.
